|View printer-friendly version|
|October 30, 2002 4:23 p.m.|
|Teva Announces Approval of 500mg/125mg Strength of Generic Version of Augmentin®|
Jerusalem, Israel, October 30, 2002 - Teva Pharmaceutical Industries Ltd. (Nasdaq:TEVA). Further to announcements made earlier in the day, Teva announced the receipt of U.S. Food and Drug Administration approval of its ANDA for Amoxicillin and Clavulanate Potassium Tablets, the generic version of GlaxoSmithKline's Augmentin® 500mg/125mg. This is the second strength of the formulation of this product for which Teva has obtained a generic drug approval.